This panel took place at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.

The panel emphasizes that Medtech innovation is driven by mission, resilience, and adaptability. Success in disruptive technologies requires embracing challenges, learning from failures, and knowing when to pivot while maintaining a strong, impact-driven vision.

This panel featured:

Lisa Carmel — Veranex

Todd Brinton — Edwards Lifesciences

Chris Carlson — Intuitive

Andrew Cleeland — Fogarty Innovation

Howard Levin — Deerfield Catalyst

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

Follow us on social:

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw